'Healthy ageing' messaging in vaccine promotion among older adults: evaluation of vaccine intention in a survey using a social marketing methodology

The dated record

Vaccine carries this cross-sectional human study with a first-publication date of August 13, 2026. The source record is titled “'Healthy ageing' messaging in vaccine promotion among older adults: evaluation of vaccine intention in a survey using a social marketing methodology.” Vitalspan Wire is publishing this retrospective on August 16, 2026; the dateline tracks the underlying paper.

What the paper examined

The paper’s question is reflected in its title: “'Healthy ageing' messaging in vaccine promotion among older adults: evaluation of vaccine intention in a survey using a social marketing methodology.” The authors’ indexed abstract closes with this signal: “Further studies should assess whether these strategies translate into sustained improvements in vaccine uptake…” That statement is the source’s interpretation and should be read within the study design.

How to read the evidence

The design measures a population at one point in time. It can identify associations, not the direction of cause and effect. The visible evidence grade reflects the central claim in this brief, not the prestige of the journal or the excitement around the mechanism.

Why it matters

The paper adds a dated piece to the aging evidence base. Its value depends on design, population, endpoint and independent replication—not novelty alone. This brief does not recommend a supplement, peptide, test or treatment.